Journal · Updated 2026-08-11

The Teaser Index: Advertised vs True GLP-1 Prices Across 37 Programs, Measured

By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify

The five mechanisms, named

Term-anchoring is the market's favorite: the headline is the longest commitment's rate. TMates' $158/$167 figures are twelve-month rates against $249/$297 month-to-month; HealthRX's ninety-nine-dollar semaglutide is the twelve-month plan with the shortest available term at one thirty-three; Trimi and LumiMeds' one twenty-five requires the entire year — roughly fifteen hundred dollars — billed upfront. Nothing here is dishonest when labeled, and our own rankings use these rates in the annual categories; the failure mode is comparing someone's twelve-month rate against someone else's monthly. Dose-anchoring advertises month one: ShedRx's one ninety-nine becomes two eighty-nine at maintenance, and Fifty 410's famous one thirty-three has no published maintenance figure at all — the pure case, unrankable by our methodology. Fee-exclusion advertises the medication and omits the mandatory membership: Mochi's one ninety-nine tirzepatide is two seventy-eight with its seventy-nine-dollar membership, Ivim's two-oh-three is two seventy-eight with its seventy-five, Hims' three ninety-nine Zepbound is five forty-eight with its one forty-nine — spreads of thirty-seven to forty percent hiding in a line item. Funnel-gating — Sprout, Synergy, Strut, Yucca's post-intake rate — puts the real number behind the intake, which is why those rows sit unrankable in our tables. And promo-anchoring: NexLife's one sixty-nine against its two-fifteen standard card is the market's clearest current example — and, labeled with its August 31 end date and Flat Forever terms as it is, also the model for how a promotional price is advertised honestly.

Where the ad and the checkout actually match

Credit where the data puts it: a meaningful cluster of programs advertise a number that survives to checkout intact. Yucca's two fifty-eight tirzepatide, SkinnyRx's and OrderlyMeds' two ninety-nine, Care Bare Rx's one ninety-nine, bmiMD's plan ladder (where the price varies by term, stated, and never by dose), Henry Meds' one seventy-nine flat, and the brand channels — LillyDirect's dose ladder and NovoCare's pen pricing are exactly what the checkout charges, refill rules and all. The pattern across the honest cluster: flat-by-dose structures, no membership line item, and either no promotion or a labeled one. That pattern is checkable before you ever reach a checkout, which makes it the fastest pre-filter this market offers.

How our database neutralizes all five

Every mechanism above is defeated by normalization, which is the entire reason the database exists: one basis (all-in monthly, maintenance dose), start and maintenance recorded separately, memberships folded into every figure, promotional rates labeled with standard rates stored beside them, and funnel-gated programs marked unrankable rather than guessed at. The teaser spreads measured on this page aren't accusations — most are legal, several are labeled, and term discounts in particular are a legitimate structure — they're the measured distance between marketing and arithmetic, published so the arithmetic wins. When your captures land the funnel-gated programs' real maintenance numbers, this index gets its last column, and this market gets its first complete one.

This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.